ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

TRML Tourmaline Bio Inc

15.04
0.04 (0.27%)
18 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Tourmaline Bio Inc TRML 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.04 0.27% 15.04 08:06:26
개장가 저가 고가 종가 전일 종가
15.00 14.64 15.45 15.04 15.00
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
16/05/202420:00GLOBETourmaline Bio Initiates Clinical Development of TOUR006 for..
14/05/202405:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/05/202420:15EDGAR2Form 8-K - Current report
13/05/202420:00GLOBETourmaline Bio Reports First Quarter 2024 Financial Results..
02/04/202420:00GLOBEAvalo Therapeutics Appoints Biotech Leaders to Board of..
19/03/202420:00GLOBETourmaline Bio Reports Fourth Quarter and Full Year 2023..
27/02/202421:30GLOBETourmaline Bio to Present at Upcoming Investor Conferences
15/02/202411:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/02/202410:51EDGAR2Form SC 13G - Statement of acquisition of beneficial..
10/02/202406:22EDGAR2Form SC 13G - Statement of acquisition of beneficial..
01/02/202422:00GLOBETourmaline Bio to Present at the Guggenheim Healthcare Talks..
30/01/202406:01GLOBETourmaline Bio Announces Closing of $172.5 Million Public..
27/01/202406:12EDGAR2Form 8-K - Current report
27/01/202406:08EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
25/01/202421:00GLOBETourmaline Bio Announces Pricing of Public Offering of..
25/01/202411:20EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
25/01/202407:10EDGAR2Form 8-K - Current report
25/01/202406:05GLOBETourmaline Bio Announces Proposed Public Offering of Common..
08/01/202423:19EDGAR2Form 8-K - Current report
08/01/202421:00GLOBETourmaline Bio Announces Expected Upcoming Key Milestones..
16/12/202306:00GLOBETourmaline Bio added to the NASDAQ Biotechnology Index
14/12/202322:27EDGAR2Form 8-K - Current report
14/12/202321:30GLOBETourmaline Bio Appoints Dr. Clay Siegall as Chairman of the..
30/11/202322:25EDGAR2Form 8-K - Current report
01/11/202321:00GLOBETourmaline Bio to Present at Upcoming Investor Conferences
24/10/202309:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202309:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202309:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202309:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202309:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202309:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202307:34EDGAR2Form 3 - Initial statement of beneficial ownership of..
20/10/202306:37GLOBETourmaline Bio Announces Closing of Merger with Talaris..